TRex Bio (TRXB) IPO deck
TRex Bio is a clinical-stage biotechnology company developing immunoregulatory medicines targeting tissue regulatory T cells to restore immune balance and tissue repair.
TRex Bio is a clinical-stage biotechnology company developing immunoregulatory medicines targeting tissue regulatory T cells to restore immune balance and tissue repair.
%20IPO%20deck){kind=link}